News + Filings Transactions Holdings
|
Lundbeckfond Invest A/S
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/09/2023 | IO Biotech, Inc. | | Grant | Warrants (Right to Buy) | 7.9M | $2.47 | $19.5M | | 08/09/2023 |
08/09/2023 | IO Biotech, Inc. | | Grant | Common Stock | 7.9M | $1.90 | $15M | | 08/09/2023 |
11/09/2021 | IO Biotech, Inc. | | Conversion | Series C Preferred Stock | 150.5k | $0.00 | $0 | | 11/09/2021 |
11/09/2021 | IO Biotech, Inc. | | Conversion | Series B Preferred Stock | 219.6k | $0.00 | $0 | | 11/09/2021 |
11/09/2021 | IO Biotech, Inc. | | Purchase | Common Stock | 2.1M | $14.00 | $30M | | 11/09/2021 |
11/09/2021 | IO Biotech, Inc. | | Conversion | Common Stock | 1.9M | $0.00 | $0 | | 11/09/2021 |
11/09/2021 | IO Biotech, Inc. | | Conversion | Common Stock | 2M | $0.00 | $0 | | 11/09/2021 |
03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 187.5k | $16.00 | $3M | | 03/16/2020 |
03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series B Preferred Stock | 1.9M | $0.00 | $0 | | 03/16/2020 |
03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series A Preferred Stock | 5.5M | $0.00 | $0 | | 03/16/2020 |
03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series Seed Preferred Stock | 478.7k | $0.00 | $0 | | 03/16/2020 |
03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 03/16/2020 |
05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Common Stock | 776.5k | $0.00 | $0 | | 05/09/2019 |
05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 375k | $10.00 | $3.8M | | 05/09/2019 |
05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series C Preferred Stock | 6.8M | $0.00 | $0 | | 05/09/2019 |
11/21/2017 | scPharmaceuticals Inc. | SCPH | Purchase | Common Stock | 654.8k | $14.00 | $9.2M | | 11/21/2017 |
11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Series A Preferred Stock | 11.1M | $0.00 | $0 | | 11/21/2017 |
11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Series B Preferred Stock | 7.1M | $0.00 | $0 | | 11/21/2017 |
11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Common Stock | 984.4k | $0.00 | $0 | | 11/21/2017 |
11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Common Stock | 1.5M | $0.00 | $0 | | 11/21/2017 |
|